Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT01305408
Armodafinil Treatment (150 mg/Day) for depression
This study is completed in the United States, in Argentina, in Brazil, .... It is testing Armodafinil Treatment (150 mg/Day) for depression.
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateMarch 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 399
- Sponsor
- Cephalon
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Argentina, Brazil, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01305408
- Official title
- A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01305408. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Argentina · 15 sites
- Teva Investigational Site 134Buenos AiresSite status: Not listed — confirm with the team
- Teva Investigational Site 136Buenos AiresSite status: Not listed — confirm with the team
- Teva Investigational Site 881Buenos AiresSite status: Not listed — confirm with the team
- Teva Investigational Site 884Buenos AiresSite status: Not listed — confirm with the team
- Teva Investigational Site 888Buenos AiresSite status: Not listed — confirm with the team
- Teva Investigational Site 236CórdobaSite status: Not listed — confirm with the team
- Teva Investigational Site 135Córdoba CapitalSite status: Not listed — confirm with the team
- Teva Investigational Site 371La PlataSite status: Not listed — confirm with the team
- Teva Investigational Site 886La PlataSite status: Not listed — confirm with the team
- Teva Investigational Site 138La Plata, Buenos AiresSite status: Not listed — confirm with the team
- Teva Investigational Site 882MendozaSite status: Not listed — confirm with the team
- Teva Investigational Site 883MendozaSite status: Not listed — confirm with the team
- Teva Investigational Site 885MendozaSite status: Not listed — confirm with the team
- Teva Investigational Site 887MendozaSite status: Not listed — confirm with the team
- Teva Investigational Site 238RosarioSite status: Not listed — confirm with the team
Brazil · 7 sites
- Teva Investigational Site 623Belo HorizonteSite status: Not listed — confirm with the team
- Teva Investigational Site 626Curitiba-ParanaSite status: Not listed — confirm with the team
- Teva Investigational Site 621Distrito de Rubiao JuniorSite status: Not listed — confirm with the team
- Teva Investigational Site 627Itapira -Sao PauloSite status: Not listed — confirm with the team
- Teva Investigational Site 624Rio de JaneiroSite status: Not listed — confirm with the team
- Teva Investigational Site 622SalvadorSite status: Not listed — confirm with the team
- Teva Investigational Site 628São PauloSite status: Not listed — confirm with the team
Bulgaria · 16 sites
- Teva Investigational Site 248BurgasSite status: Not listed — confirm with the team
- Teva Investigational Site 146KardzhaliSite status: Not listed — confirm with the team
- Teva Investigational Site 148KazanlakSite status: Not listed — confirm with the team
- Teva Investigational Site 853PazardzhikSite status: Not listed — confirm with the team
- Teva Investigational Site 852PlevenSite status: Not listed — confirm with the team
- Teva Investigational Site 145PlovdivSite status: Not listed — confirm with the team
- Teva Investigational Site 370RousseSite status: Not listed — confirm with the team
- Teva Investigational Site 147SofiaSite status: Not listed — confirm with the team
- Teva Investigational Site 149SofiaSite status: Not listed — confirm with the team
- Teva Investigational Site 244SofiaSite status: Not listed — confirm with the team
- Teva Investigational Site 247SofiaSite status: Not listed — confirm with the team
- Teva Investigational Site 854SofiaSite status: Not listed — confirm with the team
- Teva Investigational Site 855SofiaSite status: Not listed — confirm with the team
- Teva Investigational Site 245VarnaSite status: Not listed — confirm with the team
- Teva Investigational Site 851VarnaSite status: Not listed — confirm with the team
- Teva Investigational Site 856VarnaSite status: Not listed — confirm with the team
Croatia · 5 sites
- Teva Investigational Site 635RijekaSite status: Not listed — confirm with the team
- Teva Investigational Site 631SplitSite status: Not listed — confirm with the team
- Teva Investigational Site 632ZagrebSite status: Not listed — confirm with the team
- Teva Investigational Site 633ZagrebSite status: Not listed — confirm with the team
- Teva Investigational Site 634ZagrebSite status: Not listed — confirm with the team
Finland · 4 sites
- Teva Investigational Site 716HelsinkiSite status: Not listed — confirm with the team
- Teva Investigational Site 717HelsinkiSite status: Not listed — confirm with the team
- Teva Investigational Site 719KangasalaSite status: Not listed — confirm with the team
- Teva Investigational Site 718TurkuSite status: Not listed — confirm with the team
Germany · 6 sites
- Teva Investigational Site 655AchimSite status: Not listed — confirm with the team
- Teva Investigational Site 656BerlinSite status: Not listed — confirm with the team
- Teva Investigational Site 653CologneSite status: Not listed — confirm with the team
- Teva Investigational Site 651DresdenSite status: Not listed — confirm with the team
- Teva Investigational Site 654Freiburg im BreisgauSite status: Not listed — confirm with the team
- Teva Investigational Site 652MittweidaSite status: Not listed — confirm with the team
Hungary · 5 sites
- Teva Investigational Site 661BudapestSite status: Not listed — confirm with the team
- Teva Investigational Site 662BudapestSite status: Not listed — confirm with the team
- Teva Investigational Site 664BudapestSite status: Not listed — confirm with the team
- Teva Investigational Site 665GyőrSite status: Not listed — confirm with the team
- Teva Investigational Site 666NagykállóSite status: Not listed — confirm with the team
Italy · 8 sites
- Teva Investigational Site 688CataniaSite status: Not listed — confirm with the team
- Teva Investigational Site 689FlorenceSite status: Not listed — confirm with the team
- Teva Investigational Site 686GenovaSite status: Not listed — confirm with the team
- Teva Investigational Site 691Lido Di Camaiore(LU)Site status: Not listed — confirm with the team
- Teva Investigational Site 690NaplesSite status: Not listed — confirm with the team
- Teva Investigational Site 687PisaSite status: Not listed — confirm with the team
- Teva Investigational Site 693PisaSite status: Not listed — confirm with the team
- Teva Investigational Site 692RomaSite status: Not listed — confirm with the team
Poland · 7 sites
- Teva Investigational Site 259BialystokSite status: Not listed — confirm with the team
- Teva Investigational Site 257GdanskSite status: Not listed — confirm with the team
- Teva Investigational Site 258GdyniaSite status: Not listed — confirm with the team
- Teva Investigational Site 155KrakowSite status: Not listed — confirm with the team
- Teva Investigational Site 255SkorzewoSite status: Not listed — confirm with the team
- Teva Investigational Site 861SzczecinSite status: Not listed — confirm with the team
- Teva Investigational Site 157TuszynSite status: Not listed — confirm with the team
Serbia · 7 sites
- Teva Investigational Site 177BelgradeSite status: Not listed — confirm with the team
- Teva Investigational Site 831BelgradeSite status: Not listed — confirm with the team
- Teva Investigational Site 832BelgradeSite status: Not listed — confirm with the team
- Teva Investigational Site 835BelgradeSite status: Not listed — confirm with the team
- Teva Investigational Site 176KragujevacSite status: Not listed — confirm with the team
- Teva Investigational Site 837NišSite status: Not listed — confirm with the team
- Teva Investigational Site 834Novi KneževacSite status: Not listed — confirm with the team
Slovakia · 5 sites
- Teva Investigational Site 700BojniceSite status: Not listed — confirm with the team
- Teva Investigational Site 699BratislavaSite status: Not listed — confirm with the team
- Teva Investigational Site 697Rimavská SobotaSite status: Not listed — confirm with the team
- Teva Investigational Site 696RožňavaSite status: Not listed — confirm with the team
- Teva Investigational Site 698TrenčínSite status: Not listed — confirm with the team
South Africa · 7 sites
- Teva Investigational Site 707Cape TownSite status: Not listed — confirm with the team
- Teva Investigational Site 709Cape TownSite status: Not listed — confirm with the team
- Teva Investigational Site 712Cape TownSite status: Not listed — confirm with the team
- Teva Investigational Site 708CenturionSite status: Not listed — confirm with the team
- Teva Investigational Site 710JohannesburgSite status: Not listed — confirm with the team
- Teva Investigational Site 711PaarlSite status: Not listed — confirm with the team
- Teva Investigational Site 706PretoriaSite status: Not listed — confirm with the team
Ukraine · 10 sites
- Teva Investigational Site 181DnipropetrovskSite status: Not listed — confirm with the team
- Teva Investigational Site 872DonetskSite status: Not listed — confirm with the team
- Teva Investigational Site 282KharkivSite status: Not listed — confirm with the team
- Teva Investigational Site 281KievSite status: Not listed — confirm with the team
- Teva Investigational Site 180LuhanskSite status: Not listed — confirm with the team
- Teva Investigational Site 873LvivSite status: Not listed — confirm with the team
- Teva Investigational Site 875OdesaSite status: Not listed — confirm with the team
- Teva Investigational Site 183PoltavaSite status: Not listed — confirm with the team
- Teva Investigational Site 871S. OleksandrivkaSite status: Not listed — confirm with the team
- Teva Investigational Site 182VinnytsiaSite status: Not listed — confirm with the team
United States · 28 sites
- Teva Investigational Site 225Birmingham, AlabamaSite status: Not listed — confirm with the team
- Teva Investigational Site 295Sherman Oaks, CaliforniaSite status: Not listed — confirm with the team
- Teva Investigational Site 122Temecula, CaliforniaSite status: Not listed — confirm with the team
- Teva Investigational Site 606Jacksonville Beach, FloridaSite status: Not listed — confirm with the team
- Teva Investigational Site 127Lauderhill, FloridaSite status: Not listed — confirm with the team
- Teva Investigational Site 608Tampa, FloridaSite status: Not listed — confirm with the team
- Teva Investigational Site 116Atlanta, GeorgiaSite status: Not listed — confirm with the team
- Teva Investigational Site 205Atlanta, GeorgiaSite status: Not listed — confirm with the team
- Teva Investigational Site 195Park Ridge, IllinoisSite status: Not listed — confirm with the team
- Teva Investigational Site 611Indianapolis, IndianaSite status: Not listed — confirm with the team
- Teva Investigational Site 600Lafayette, IndianaSite status: Not listed — confirm with the team
- Teva Investigational Site 603Watertown, MassachusettsSite status: Not listed — confirm with the team
- Teva Investigational Site 207Brooklyn, New YorkSite status: Not listed — confirm with the team
- Teva Investigational Site 202New York, New YorkSite status: Not listed — confirm with the team
- Teva Investigational Site 110Staten Island, New YorkSite status: Not listed — confirm with the team
- Teva Investigational Site 411Staten Island, New YorkSite status: Not listed — confirm with the team
- Teva Investigational Site 614Wilmington, North CarolinaSite status: Not listed — confirm with the team
- Teva Investigational Site 610Cincinnati, OhioSite status: Not listed — confirm with the team
- Teva Investigational Site 615Toledo, OhioSite status: Not listed — confirm with the team
- Teva Investigational Site 401Oklahoma City, OklahomaSite status: Not listed — confirm with the team
- Teva Investigational Site 609Oklahoma City, OklahomaSite status: Not listed — confirm with the team
- Teva Investigational Site 616Oklahoma City, OklahomaSite status: Not listed — confirm with the team
- Teva Investigational Site 406Allentown, PennsylvaniaSite status: Not listed — confirm with the team
- Teva Investigational Site 403DeSoto, TexasSite status: Not listed — confirm with the team
- Teva Investigational Site 612Friendswood, TexasSite status: Not listed — confirm with the team
- Teva Investigational Site 408Salt Lake City, UtahSite status: Not listed — confirm with the team
- Teva Investigational Site 613Kirkland, WashingtonSite status: Not listed — confirm with the team
- Teva Investigational Site 605Spokane, WashingtonSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Armodafinil, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Cephalon, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT00223496
12- Week Open Label Treatment of Refractory Depression in bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
CompletedNCT02363738
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
This study is completed. It focuses on bipolarity and currently lists study information in Canada and the United States.
CompletedNCT03902613
18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.